Hostname: page-component-848d4c4894-tn8tq Total loading time: 0 Render date: 2024-07-03T14:15:47.693Z Has data issue: false hasContentIssue false

Neuroendocrine Responses As an Indicator of Recurrence Liability in Primary Affective Illness

Published online by Cambridge University Press:  29 January 2018

Eva Grof
Affiliation:
Departments of Psychiatry and Neurosciences, McMaster University, Hamilton, Ontario
Gregory M. Brown
Affiliation:
Departments of Psychiatry and Neurosciences, McMaster University, Hamilton, Ontario
Paul Grof
Affiliation:
Departments of Psychiatry and Neurosciences, McMaster University, Hamilton, Ontario
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
Copyright © Royal College of Psychiatrists, 1982 

References

1 Carroll, B. J., Feinberg, M., Greden, J. F., Tarika, J., Albala, A., Haskett, R., James, N., Kronfol, Z., Lohr, N., Steiner, M., DeVigne, J. P. & Young, E. (1981) A specific laboratory test for the diagnosis of melancholia. Archives of General Psychiatry, 38, 1522.Google Scholar
2 Albala, A. A., Greden, J. F., Tarika, J. & Carroll, B. J. (1981) Changes in serial dexamethasone suppression tests among unipolar depressives receiving electroconvulsive treatment. Biological Psychiatry, in press.Google Scholar
3 de la Fuente, J. & Rosenbaum, A. H. (1980) Neuroendocrine dysfunction and blood levels of tricyclic antidepressants. American Journal of Psychiatry, 137, 1260–1.Google Scholar
4 Goldberg, I. K. (1980) Dexamethasone suppression test as an indicator of safe withdrawal of antidepressant therapy. Lancet, i, 376.Google Scholar
5 Goldberg, I. K. (1980) Dexamethasone suppression tests in depression and response to treatment. Lancet, ii, 92.Google Scholar
6 Greden, J. F., DeVigne, J. P., Albala, A. A., Tarika, J., Buttenhiem, M., Eiser, A. & Carroll, B. J. (1981) Post-dexamethasone plasma Cortisol levels among lithium treated rapidly cycling bipolar patients. In The Prediction of Lithium Response (ed. Dufour, H.). Paris: Economica, in press.Google Scholar
7 Kirkegaard, C., Norlem, N., Lauridsen, U. B. & Bjoerum, N. (1980) Prognostic value of thyrotropin-releasing hormone stimulation test in endogenous depression. Acta Psychiatrica Scandinavica, 52, 170–7.Google Scholar
8 Kirkegaard, C. & Bjoerum, N. (1980) TSH responses to TRH in endogenous depression. Lancet, i, 152.Google Scholar
9 Langer, G., Schonbeck, G., Koinig, G., Schussler, M. & Reiter, H. (1980) Neuroendocrine status of depressed patients at admission and during antidepressant drug treatment (Clomipramine). Neuropsychobiology, 6, 153.Google Scholar
10 Langer, G., Schonbeck, G., Koinig, G. & Aschauer, H. (1981) Neuroendocrine mechanisms in therapeutic effects of antidepressant drugs: The “Thyroid axis” hypothesis. Presentation—3rd World Congress Biological Psychiatry, Stockholm. Abstracts S-211.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.